Breaking News
Get 40% Off 0
🔎 See NVDA full ProTips for an instant risks or rewards Claim 40% OFF
Close

Novartis AG (NOVZn)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
80.16 0.00    0.00%
28/06 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  CH0012005267 
S/N:  904278
  • Volume: 0
  • Bid/Ask: 80.11 / 80.34
  • Day's Range: 79.94 - 80.34
Novartis 80.16 0.00 0.00%

NOVZn Balance Sheet

 
Featured here, the Balance Sheet for Novartis AG, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 30481 45660 33493 32114
Cash and Short Term Investments 14073 12816 11072 12187
Cash - - - -
Cash & Equivalents 13393 12405 10885 12000
Short Term Investments 680 411 187 187
Total Receivables, Net 9247 7099 9543 9183
Accounts Receivables - Trade, Net 7107 6819 9195 8916
Total Inventory 5913 5610 8228 7886
Prepaid Expenses 764 - - -
Other Current Assets, Total 484 20135 4650 2858
Total Assets 99945 112697 110979 112241
Property/Plant/Equipment, Total - Net 10924 10344 12277 12348
Property/Plant/Equipment, Total - Gross 22803 - - -
Accumulated Depreciation, Total -11879 - - -
Goodwill, Net 23341 23416 29522 29481
Intangibles, Net 26879 26418 28003 30451
Long Term Investments 1827 1530 1758 1788
Note Receivable - Long Term 2140 280 348 267
Other Long Term Assets, Total 1966 1701 1883 1978
Other Assets, Total 2357 22685 7565 5829
Total Current Liabilities 26390 48393 31909 30549
Accounts Payable 4926 3870 5350 5426
Payable/Accrued - - - -
Accrued Expenses 5174 - - -
Notes Payable/Short Term Debt 3893 - - -
Current Port. of LT Debt/Capital Leases 2512 5668 8536 7219
Other Current liabilities, Total 9885 38855 18023 17904
Total Liabilities 53195 74452 59048 60099
Total Long Term Debt 20034 19521 19804 21985
Long Term Debt 18436 18068 18259 20396
Capital Lease Obligations 1598 1453 1545 1589
Deferred Income Tax 2248 2457 2526 2727
Minority Interest 83 81 84 83
Other Liabilities, Total -119 2993 3718 3748
Total Equity 46750 38245 51931 52142
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 825 825 842 842
Additional Paid-In Capital - - - -
Retained Earnings (Accumulated Deficit) 49649 42333 55682 56089
Treasury Stock - Common -41 -32 -52 -36
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -3683 -4881 -4541 -4753
Total Liabilities & Shareholders' Equity 99945 112697 110979 112241
Total Common Shares Outstanding 2044.03 2055.46 2068.26 2097.4
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NOVN Comments

Write your thoughts about Novartis AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email